Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

(1) Background: The association between proton pump inhibitor (PPI) use and hepatocellular carcinoma (HCC) has been controversial, especially in the general population. We aimed to determine the impact of PPI on HCC risk in participants without liver cirrhosis or chronic hepatitis virus infection. (...

Full description

Bibliographic Details
Main Authors: Soungmun Kim, Seogsong Jeong, Sun Jae Park, Jooyoung Chang, Seulggie Choi, Yoosun Cho, Joseph C. Ahn, Gyeongsil Lee, Joung Sik Son, Sang Min Park
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
epidemiology
pharmacoepidemiology
proton pump inhibitor
hepatocellular carcinoma
liver cirrhosis
chronic liver diseases
Online Access:https://www.mdpi.com/2077-0383/11/10/2865

Internet

https://www.mdpi.com/2077-0383/11/10/2865

Similar Items